Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
1.16K
-
Shares change
-
-39.8M
-
Total reported value, excl. options
-
$38.1K
-
Value change
-
-$1.32B
-
Number of sells
-
-118
-
Price
-
$32.92
Significant Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q4 2024
121 filings reported holding LBPH - LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share as of Q4 2024.
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.16K shares
.
Largest 10 shareholders include Candriam S.C.A. (0 shares), GAMMA Investing LLC (0 shares), Smartleaf Asset Management LLC (0 shares), JONES FINANCIAL COMPANIES LLLP (0 shares), CIBC Asset Management Inc (0 shares), PNC Financial Services Group, Inc. (0 shares), BRAUN STACEY ASSOCIATES INC (0 shares), NISA INVESTMENT ADVISORS, LLC (0 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (0 shares), and Mesirow Financial Investment Management, Inc. (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.